Fig. 14

Effects of TP53/p53 mutation in RCC on patient survival probability: Kaplan-Meier survival analyses of the OS from TCGA-RCC cohorts of ccRCC (A), chRCC (B) and pRCC (C) were presented. Patients were grouped based on TP53/p53 mutation status. The log-rank test was used to determine the difference of OS for patients with TP53/p53 somatic mutation (red) versus without somatic mutation (blue). The figure was performed using R version 4.0.3